Hi Sabine, always a good sign when you start researching. A lot of things are uncovered...
I have a question. It appears they only needed 108 patients in a randomised phase and 75 in a single arm phase to meet the FDAs requirements for approval. This seems awfully low. Is that your understanding? I am interested for my research on another share and would be over the moon if that is it.
Hi Sabine, always a good sign when you start researching. A lot...
Add EBR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
90.5¢ |
Change
0.035(4.02%) |
Mkt cap ! $313.0M | |||
| Open | High | Low | Value | Volume |
| 87.0¢ | 92.5¢ | 86.0¢ | $453.2K | 506.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1645 | 90.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 91.0¢ | 7232 | 3 |
View Market Depth
| Last trade - 13.01pm 01/10/2024 (20 minute delay) ? |
| EBR (ASX) Chart |